nach oben

Journal of Cancer Education

Erschienen in:

01.09.2013

Mini-review on Glycolysis and Cancer

verfasst von: M. Akram

Erschienen in: Journal of Cancer Education | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Glycolysis is a universal pathway in the living cells. The complete pathway of glycolysis was elucidated in 1940. This pathway is often referred to as Embden–Meyerhof pathway in honor of the two biochemists that made a major contribution to the knowledge of glycolysis. The objective of the study was to review the published literature on glycolysis and relation to cancer. The material for this review was taken mostly from up-to-date biochemistry textbooks and electronic journals. To collect publications, PubMed and the Cochrane database of systematic reviews were used. Some other relevant references were collected from personal database of papers on glycolysis and cancer. Several glycolytic inhibitors are currently in preclinical and clinical development. Inhibition of glycolysis in cancer cells is a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. This article is an important topic to be considered by cancer researchers and those who treat cancers.

Bacci G, Capanna R, Orlandi M (1985) Prognostic significance of serum lactic acid dehydrogenase in Ewing’s tumor of bone. Ric Clin Lab 15:89–96PubMed

Veramendi J, Fernie AR, Leisse A, Willmitzer L, Trethewey RN (2002) Potato hexokinase 2 complements transgenic Arabidopsis plants deficient in hexokinase 1 but does not play a key role in tuber carbohydrate metabolism. Plant Mol Biol 49:491–501PubMedCrossRef

Tang GQ, Hardin SC, Dewey R, Huber SC (2003) A novel C-terminal proteolytic processing of cytosolic pyruvate kinase, its phosphorylation and degradation by the proteasome in developing soybean seeds. Plant J 34:77–93PubMedCrossRef

Goldblatt H, Cameron C (1953) Induced malignancy in cells from rat myocardium subjected to intermittent anaerobiosis during long propagation in vitro. J Exp Med 97:525–552PubMedCrossRef

Druml W, Kleinberger G, Neumann E, Pichler M, Gassner A (1981) [Acute leukemia associated with lactic acidosis] [article in German]. Schweiz Med. Wochenschr 111:146–150

Allard MF, Schönekess BO, Henning SL, English DR, Lopaschuk GD (2008) Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 267(2):742–750

Pérez-Rodríguez J, Sánchez-Jiménez F, Márquez FJ, Medina MA, Quesada AR, Núñez de Castro I (1987) Malate-citrate cycle during glycolysis and glutaminolysis in Ehrlich ascites tumor cells. Biochimie 69(5):469–474PubMedCrossRef

Warburg O (1910) The metabolism of tumours. J Physiol Chem 56:66–305

Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277:23111–23115PubMedCrossRef

10.

Schwickert G, Walenta S, Sundfør K, Rofstad EK, Mueller-Klieser W (1995) Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 55:4757–4759PubMed

11.

Sun RC, Fadia M, Dahlstrom JE, Parish CR, Board PG, Blackburn AC (2009) Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat 120(1):253–260PubMedCrossRef

12.

Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P (2005) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65(2):613–621PubMed

13.

Altenberg B, Greulich KO (2008) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84(6):1014–1020CrossRef

14.

Broadley K, Larsen L, Herst PM, Smith RA, Berridge MV, McConnell MJ (2011) The novel phloroglucinol PMT7 kills glycolytic cancer cells by blocking autophagy and sensitizing to nutrient stress. J Cell Biochem 112(7):1869–1879PubMedCrossRef

15.

Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9(6):425–434PubMedCrossRef

16.

Ha TK, Her NG, Lee MG, Ryu BK, Lee JH, Han J, Jeong SI, Kang MJ, Kim NH, Kim HJ, Chi SG (2012) Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res 72(16):4097–4109PubMedCrossRef

17.

Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B (2002) Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs 17(10):1533–1545CrossRef

18.

Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y, Feng Y, Li L, Wang Y, Liu X, Chen H, Liu XY, Ji H (2012) MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem 287(27):23227–2335PubMedCrossRef

19.

Granchi C, Minutolo F (2012) Anticancer agents that counteract tumor glycolysis. ChemMedChem 7(8):1318–1350PubMedCrossRef

20.

Sukhatme VP, Chan B (2012) Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. FEBS Lett 586(16):2389–2395PubMedCrossRef

21.

Wang MD, Shi YF, Wang H, Wang JL, Ma WB, Wang RZ. Virtual mutagenesis of isocitrate dehydrogenase 1 involved in glioblastoma multiforme. Chin Med J 124(17):2611–2615)

22.

Koebmann BJ, Westerhoff HV, Snoep JL, Nilsson D, Jensen PR (2002) The glycolytic flux in Escherichia coli is controlled by the demand for ATP. J Bacteriol 184:3909–3916PubMedCrossRef

23.

Guyton A, Hall J (1996) Textbook of medical physiology, 9th edn. W.B. Saunders, Philadelphia, PA, pp 868–870

24.

Fernie AR, Roscher A, Ratcliffe RG, Kruger NJ (2011) Fructose 2,6-bisphosphate activates pyrophosphate: fructose 6-phosphate 1-phosphotransferase and increases triose phosphate to hexose phosphate cycling in heterotrophic cells. Planta 212:250–263CrossRef

25.

Mulquiney PJ, Bubb WA, Kuchel PW. Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: in vivo kinetic characterization of 2,3-bisphosphoglycerate synthase/phosphatase using 13C and 31P NMR. Biochem J 342 (3):567–580

Titel: Mini-review on Glycolysis and Cancer
verfasst von: M. Akram
Publikationsdatum: 01.09.2013
Verlag: Springer US
Erschienen in: Journal of Cancer Education / Ausgabe 3/2013
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-013-0486-9

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Mini-review on Glycolysis and Cancer

Abstract

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Time Availability and Preference for e-Health Communication Channels for Nutrition and Physical Activity

From Adolescent Daughter to Mother: Exploring Message Design Strategies for Breast and Cervical Cancer Prevention and Screening

Understanding the Needs of Colorectal Cancer Patients during the Pre-diagnosis Phase

The Bottleneck Effect in Lung Cancer Clinical Trials

Men’s Experience with Sexual Dysfunction Post-rectal Cancer Treatment: A Qualitative Study

Identifying Health Literacy and Health System Navigation Needs among Rural Cancer Patients: Findings from the Rural Oncology Literacy Enhancement Study (ROLES)

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie